Literature DB >> 11012977

Evidence for determining parasitic factors in addition to host genetics and immune status in the outcome of murine Leishmania infantum visceral leishmaniasis.

J P Gangneux1, A Sulahian, S Honore, P Meneceur, F Derouin, Y J Garin.   

Abstract

C.B-17 SCID and congenic BALB/C mice were used to examine Leishmania infantum strain pathogenicity independently of host genetic factors. While parasite loads were significantly higher in immunodeficient mice than in immunocompetent mice, the kinetics of infection during a long-term follow-up were similar, suggesting that intrinsic parasitic factors also influence the outcome of L. infantum infection.

Entities:  

Mesh:

Year:  2000        PMID: 11012977     DOI: 10.1046/j.1365-3024.2000.00332.x

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  4 in total

1.  Virulence of Leishmania infantum is expressed as a clonal and dominant phenotype in experimental infections.

Authors:  Y J Garin; A Sulahian; F Pratlong; P Meneceur; J P Gangneux; E Prina; J P Dedet; F Derouin
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

2.  Characterization of the biology and infectivity of Leishmania infantum viscerotropic and dermotropic strains isolated from HIV+ and HIV- patients in the murine model of visceral leishmaniasis.

Authors:  Joana Cunha; Eugenia Carrillo; Carmen Sánchez; Israel Cruz; Javier Moreno; Anabela Cordeiro-da-Silva
Journal:  Parasit Vectors       Date:  2013-04-26       Impact factor: 3.876

3.  Genetic evidence of functional ficolin-2 haplotype as susceptibility factor in cutaneous leishmaniasis.

Authors:  Amal Assaf; Tong Van Hoang; Imad Faik; Toni Aebischer; Peter G Kremsner; Jürgen F J Kun; T P Velavan
Journal:  PLoS One       Date:  2012-03-23       Impact factor: 3.240

Review 4.  Study of Leishmania pathogenesis in mice: experimental considerations.

Authors:  Corinne Loeuillet; Anne-Laure Bañuls; Mallorie Hide
Journal:  Parasit Vectors       Date:  2016-03-11       Impact factor: 3.876

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.